期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

糖化血红蛋白对冠状动脉支架置入后再狭窄的临床意义

下载PDF
导出
摘要 糖化血红蛋白（HbA1c）作为糖尿病疗效评定的监测指标以及微血管病变的生化标志正受到临床重视.研究显示HbA1c在预测心血管事件、心血管死亡、总死亡危险方面具有广泛的价值[1],但有关HbA1c水平与冠状动脉支架置入后再狭窄的关系报道较少.本文分析2008年-2010年我院收治的52例成功冠状动脉支架置入患者HbA1c水平,探讨HbA1c对冠状动脉支架置入后再狭窄的临床意义.
作者 李瑾 张玉平
机构地区 山西省长治市人民医院
出处 《中西医结合心脑血管病杂志》 2011年第6期676-677,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 冠状动脉支架置入 糖化血红蛋白 临床意义 后再狭窄 HBA1C 心血管事件 死亡危险 微血管病变
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献6

  • 1Alberecht C,Simon-Vermot I,Temothy L,et al.Leukocyte ABCA1 gene expression is a associated with fasting glucose concentration in normoglycemicmen[J].Metabolism,2004,53:17-21.
  • 2Ulus T,Yildirir A,Demirtas S,et al.Serum gamma-glutamyltransferase activity:A new marker for stent restenosis[J].Atherosclerosis,2007,195(2):348-353.
  • 3Imamura K,Ito H,Ikushima M,et al.Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction[J].J Am Coll Cardiol,2003,417.
  • 4Vulic D,Lee BT,Dede J,et al.Extent of control of cardiovascular risk factors and adherence to recommended therapies in US multiethnic adults with coronary heart disease:From a 2005-2006 National Survey[J].Am J Cardiovasc Drugs,2010,10:109-l14.
  • 5田磊,米树华,苏工,陶红,赵全明,周芸.非糖尿病人群糖化血红蛋白水平与冠心病发病的关系[J].中国糖尿病杂志,2007,15(10):598-600. 被引量：24
  • 6Khan HA,Sobki SH,Khan SA.Association between glycaemic control and sertun lipids profile in type 2 diabetic patients:HbAlc predicts dyslipidaemia[J].Clin Exp Med,2007,48(1):1120-1124.

二级参考文献10

  • 1Khaw KT,Wareham N,Bingham S,et al.Association of hemoglobin Alc with cardiovascular disease and mortality in adults:the European prospective investigation into cancer in Norfolk.Ann Intem Med,2004,141:413 -420.
  • 2Rubany GM.Cardiovascular significance of endothelium derived vasoaction factors.New York:Future publishing Co Inc,1991:364.
  • 3Singer DE,Nathan DM,Keavea MA,et al.Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study.Diabetes,1992,41:202-208.
  • 4Vitelli LL,Shahar E,Heiss G,et al.Glycosylated hemoglobin level and carotid intimal-medial thickening in.Diabetes Care,1997,20:1454-1458.
  • 5Park S,Barrett-Connor E,Wingard DL,et al.Ghb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes.The Rancho Bemardo study.Diabetes Care,1996,19:450-456.
  • 6De Vegt F,Dekker JM,Ruhe HG,et al.Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population:the Hoorn Study.Diabetologia,1999,42:926 -931.
  • 7Bogaty P,Brecker SJ,White SE,et al.Comparison of coronary angiographic findings in acute and chronic first presentation of ischemc heart disease.Circulation,1993,87:1938-1947.
  • 8Gerstein HC.Glycosylated hemoglobin:finally ready for prime time as a cardiovascular risk factor.Ann Intern Med,2004,141:475-476.
  • 9KhawKT,Wareham N,Luben R,et al.Glycated haemoglobin,diabetes,and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPICN-orfolk).BMJ,2001,322:15-18.
  • 10Robert A,Corpus MD,William W,et al.Relation of hemoglobinA1c to rate of major asvers cardiac events in non-diabetic patients undergoing percutaneous coronary revascularization.Am J Cardiol,2003,92:1282-1286.

共引文献23

中西医结合心脑血管病杂志
2011年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部